ื™ื•ื ืฉืœื™ืฉื™, 11 ืื•ื’ื•ืกื˜ 2026

tranexamic acid (TXA)

ื—ื“ืฉื•ืช ืžืชืคืจืฆื•ืช 9 ื—ื•ื“ืฉื™ื ืœืคื ื™

ืืจื”"ื‘ ื‘ื•ื—ื ืช ืืช "ืจืคื" ื”ื™ืฉืจืืœื™ืช ืœืงื™ื“ื•ื ื˜ื™ืคื•ืœ ืžืฆื™ืœ ื—ื™ื™ื ื‘ื“ื™ืžื•ืžื™ื ื˜ืจื•ื-ื‘ื™ืช ื—ื•ืœื™ื

ืืจื”"ื‘ ืคื•ื ื” ืœื™ืฉืจืืœ ื‘ืชื—ื•ื ื”ื˜ื™ืคื•ืœ ื”ืจืืฉื•ื ื™ ืžืฆื™ืœ ื—ื™ื™ื ื‘ื“ื™ืžื•ืžื™ื, ืขื ื—ื•ื–ื” ื—ื“ืฉ ื‘ืกืš 186 ืžื™ืœื™ื•ืŸ ื“ื•ืœืจ ืœืคื•ืจืžื•ืœืฆื™ื™ืช TXA ืชื•ืš-ืฉืจื™ืจื™ืช.

ืžืงื•ืจ: ืคืกื— ื‘ื ืกื•ืŸ